How Can Implementation Science Improve the Care of Familial Hypercholesterolaemia?

Curr Atheroscler Rep. 2023 Apr;25(4):133-143. doi: 10.1007/s11883-023-01090-6. Epub 2023 Feb 20.

Abstract

Purpose of review: Describe the application of implementation science to improve the detection and management of familial hypercholesterolaemia.

Recent findings: Gaps between evidence and practice, such as underutilization of genetic testing, family cascade testing, failure to achieve LDL-cholesterol goals and low levels of knowledge and awareness, have been identified through clinical registry analyses and clinician surveys. Implementation science theories, models and frameworks have been applied to assess barriers and enablers in the literature specific to local contextual factors (e.g. stages of life). The effect of implementation strategies to overcome these factors has been evaluated; for example, automated identification of individuals with FH or training and education to improve statin adherence. Clinical registries were identified as a key infrastructure to monitor, evaluate and sustain improvements in care. The expansion in evidence supporting the care of familial hypercholesterolaemia requires a similar expansion of efforts to translate new knowledge into clinical practice.

Keywords: Cholesterol; Clinical practice guidelines; Detection; Familial hypercholesterolaemia; Implementation science; Statins.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cholesterol, LDL
  • Genetic Testing
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
  • Hyperlipoproteinemia Type II* / diagnosis
  • Hyperlipoproteinemia Type II* / genetics
  • Hyperlipoproteinemia Type II* / therapy
  • Implementation Science

Substances

  • Cholesterol, LDL
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors